![Christopher Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Murray
Nessuna posizione attualmente
Profilo
Christopher K.
Murray worked at ARIAD Pharmaceuticals, Inc. from 2004 to 2017, serving as Vice President-Technical Operations from 2013 to 2017.
Dr. Murray worked at Blueprint Medicines Corp.
from 2017 to 2025, serving as Chief Technical Operations & Quality Officer.
Dr. Murray completed undergraduate studies at Hope College in 1984 and graduate studies at The University of Chicago in 1990.
Ultime notizie su Christopher Murray
Precedenti posizioni note di Christopher Murray
| Società | Posizione | Fine |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/04/2025 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2017 |
Formazione di Christopher Murray
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
